237 related articles for article (PubMed ID: 28210079)
21. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
Goren I; Yahav L; Tulchinsky H; Dotan I
Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
[TBL] [Abstract][Full Text] [Related]
22. Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome.
Huong BT; Hien NM; Dung NT; Quang DM; Vinh NT; Tu TT; Chi TK; Phuong LB; Nhan NT
Med Arch; 2024; 78(2):105-111. PubMed ID: 38566874
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
[TBL] [Abstract][Full Text] [Related]
24. New serological markers in pediatric patients with inflammatory bowel disease.
Kovács M; Müller KE; Papp M; Lakatos PL; Csöndes M; Veres G
World J Gastroenterol; 2014 May; 20(17):4873-82. PubMed ID: 24803798
[TBL] [Abstract][Full Text] [Related]
25. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
26. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior.
Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
Inflamm Bowel Dis; 2010 Feb; 16(2):263-74. PubMed ID: 19653286
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
[TBL] [Abstract][Full Text] [Related]
28. Serological markers predict inflammatory bowel disease years before the diagnosis.
van Schaik FD; Oldenburg B; Hart AR; Siersema PD; Lindgren S; Grip O; Teucher B; Kaaks R; Bergmann MM; Boeing H; Carbonnel F; Jantchou P; Boutron-Ruault MC; Tjønneland A; Olsen A; Crowe FL; Peeters PH; van Oijen MG; Bueno-de-Mesquita HB
Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study.
Yao F; Fan Y; Lv B; Ji C; Xu L
Medicine (Baltimore); 2018 Aug; 97(32):e11772. PubMed ID: 30095633
[TBL] [Abstract][Full Text] [Related]
30. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
Frehn L; Jansen A; Bennek E; Mandic AD; Temizel I; Tischendorf S; Verdier J; Tacke F; Streetz K; Trautwein C; Sellge G
PLoS One; 2014; 9(9):e106750. PubMed ID: 25215528
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory bowel disease serology in Asia and the West.
Prideaux L; Kamm MA; De Cruz P; van Langenberg DR; Ng SC; Dotan I
World J Gastroenterol; 2013 Oct; 19(37):6207-13. PubMed ID: 24115818
[TBL] [Abstract][Full Text] [Related]
32. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
33. Antiglycan antibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Drygiannakis D; Tsirogianni A; Oustamanolakis P; Karmiris K; Papamichael K; Mantzaris GJ; Kouroumalis EA
Dig Dis Sci; 2011 Mar; 56(3):845-52. PubMed ID: 20632100
[TBL] [Abstract][Full Text] [Related]
34. The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.
Ono Y; Kanmura S; Morinaga Y; Oda K; Kawabata K; Arima S; Sasaki F; Nasu Y; Tanoue S; Hashimoto S; Taguchi H; Uto H; Tsubouchi H; Ido A
BMC Gastroenterol; 2017 Mar; 17(1):40. PubMed ID: 28284201
[TBL] [Abstract][Full Text] [Related]
35. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
[No Abstract] [Full Text] [Related]
36. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
37. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity.
Oikonomou KA; Kapsoritakis AN; Theodoridou C; Karangelis D; Germenis A; Stefanidis I; Potamianos SP
J Gastroenterol; 2012 May; 47(5):519-30. PubMed ID: 22200942
[TBL] [Abstract][Full Text] [Related]
39. Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis.
Zilberman L; Maharshak N; Arbel Y; Rogowski O; Rozenblat M; Shapira I; Berliner S; Arber N; Dotan I
Digestion; 2006; 73(4):205-9. PubMed ID: 16837810
[TBL] [Abstract][Full Text] [Related]
40. Anti-food and anti-microbial IgG subclass antibodies in inflammatory bowel disease.
Jansen A; Mandić AD; Bennek E; Frehn L; Verdier J; Tebrügge I; Lutz H; Streetz K; Trautwein C; Sellge G
Scand J Gastroenterol; 2016 Dec; 51(12):1453-1461. PubMed ID: 27455092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]